Advertisement
AMED vs USPH
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMED is a Hold and USPH is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMED’s FA Score shows that 0 FA rating(s) are green whileUSPH’s FA Score has 0 green FA rating(s).
- AMED’s FA Score: 0 green, 5 red.
- USPH’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMED’s TA Score shows that 4 TA indicator(s) are bullish while USPH’s TA Score has 5 bullish TA indicator(s).
- AMED’s TA Score: 4 bullish, 4 bearish.
- USPH’s TA Score: 5 bullish, 5 bearish.
Price Growth
AMED (@Hospital/Nursing Management) experienced а +0.05% price change this week, while USPH (@Hospital/Nursing Management) price change was -2.17% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +1.78%. For the same industry, the average monthly price growth was +0.43%, and the average quarterly price growth was +6.39%.
Reported Earning Dates
AMED is expected to report earnings on Oct 29, 2025.
USPH is expected to report earnings on Nov 11, 2025.
Industries' Descriptions
@Hospital/Nursing Management (+1.78% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| AMED | USPH | AMED / USPH | |
| Capitalization | 3.32B | 1.3B | 255% |
| EBITDA | 239M | 91.6M | 261% |
| Gain YTD | 11.235 | -2.164 | -519% |
| P/E Ratio | 39.30 | 37.46 | 105% |
| Revenue | 2.4B | 699M | 344% |
| Total Cash | 337M | 39.2M | 860% |
| Total Debt | 451M | 307M | 147% |
AMED | USPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 12 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 87 | |
SMR RATING 1..100 | 79 | 80 | |
PRICE GROWTH RATING 1..100 | 51 | 46 | |
P/E GROWTH RATING 1..100 | 36 | 96 | |
SEASONALITY SCORE 1..100 | 39 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
USPH's Valuation (57) in the Medical Or Nursing Services industry is in the same range as AMED (78). This means that USPH’s stock grew similarly to AMED’s over the last 12 months.
USPH's Profit vs Risk Rating (87) in the Medical Or Nursing Services industry is in the same range as AMED (100). This means that USPH’s stock grew similarly to AMED’s over the last 12 months.
AMED's SMR Rating (79) in the Medical Or Nursing Services industry is in the same range as USPH (80). This means that AMED’s stock grew similarly to USPH’s over the last 12 months.
USPH's Price Growth Rating (46) in the Medical Or Nursing Services industry is in the same range as AMED (51). This means that USPH’s stock grew similarly to AMED’s over the last 12 months.
AMED's P/E Growth Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for USPH (96). This means that AMED’s stock grew somewhat faster than USPH’s over the last 12 months.
| AMED | USPH | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 33% | 3 days ago 62% |
| Stochastic ODDS (%) | 3 days ago 51% | 3 days ago 72% |
| Momentum ODDS (%) | 3 days ago 44% | 3 days ago 62% |
| MACD ODDS (%) | 3 days ago 37% | 3 days ago 67% |
| TrendWeek ODDS (%) | 3 days ago 44% | 3 days ago 68% |
| TrendMonth ODDS (%) | 3 days ago 35% | 3 days ago 67% |
| Advances ODDS (%) | 4 days ago 47% | 5 days ago 63% |
| Declines ODDS (%) | 17 days ago 58% | 3 days ago 68% |
| BollingerBands ODDS (%) | 3 days ago 53% | 3 days ago 74% |
| Aroon ODDS (%) | 3 days ago 28% | 3 days ago 60% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FCGYX | 20.34 | 0.03 | +0.15% |
| NYLI PineStone Global Equity Class C | |||
| FLUAX | 28.39 | -0.06 | -0.21% |
| Fidelity Advisor Stk Selec Lg Cp Val A | |||
| CBLCX | 55.29 | -0.16 | -0.29% |
| Columbia Balanced C | |||
| SUVAX | 12.58 | -0.05 | -0.40% |
| PGIM Quant Solutions Large-Cap Val A | |||
| PSBMX | 27.03 | -0.12 | -0.44% |
| Principal SmallCap R3 | |||
AMED and
Correlation & Price change
A.I.dvisor tells us that AMED and FMCQF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMED and FMCQF's prices will move in lockstep.
| Ticker / NAME | Correlation To AMED | 1D Price Change % | ||
|---|---|---|---|---|
| AMED | 100% | N/A | ||
| FMCQF - AMED | 24% Poorly correlated | -0.11% | ||
| OPCH - AMED | 23% Poorly correlated | -0.32% | ||
| EHAB - AMED | 21% Poorly correlated | +2.30% | ||
| USPH - AMED | 21% Poorly correlated | -0.23% | ||
| BKD - AMED | 20% Poorly correlated | -0.27% | ||
More | ||||
USPH and
Correlation & Price change
A.I.dvisor indicates that over the last year, USPH has been loosely correlated with NHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if USPH jumps, then NHC could also see price increases.
| Ticker / NAME | Correlation To USPH | 1D Price Change % | ||
|---|---|---|---|---|
| USPH | 100% | -0.23% | ||
| NHC - USPH | 46% Loosely correlated | +1.08% | ||
| ENSG - USPH | 43% Loosely correlated | +0.10% | ||
| CON - USPH | 43% Loosely correlated | -0.64% | ||
| PNTG - USPH | 43% Loosely correlated | +2.27% | ||
| AVAH - USPH | 39% Loosely correlated | -1.67% | ||
More | ||||